Level I evidence provided for pain relief from 1 kHz to 10 kHz with...

The final of the PROCO trial results showed that patients received equivalent pain relief from 1 kHz to 10 kHz with appropriate neural dosing...

Nuvectra issues update on US FDA and CE mark applications for Virtis device

Nuvectra has issued an update on its US Food and Drug Administration (FDA) pre-market approval (PMA) application and its application for CE mark in...

DBS treatment may slow the progression of parkinson’s tremor in early-stage patients

A study at Vanderbilt University Medical Centre, Nashville, USA has provided the first evidence of a treatment that slows the progression of one of...

Christopher M Smith joins Neuromod Board as strategic advisor

Neuromod Devices Limited (“Neuromod”), an Irish medical technology company specialising in non-invasive neuromodulation technologies, has announced that Christopher M Smith became Strategic Advisor to...

Gregory Albers

Simon Thomson

Laurent Pierot

(Visited 2,407 times, 2 visits today)